Israeli Pharma Giant Teva Donates Medicines for New NIH COVID-19 Treatment Study | Algemeiner
The US National Institutes of Health (NIH) said on Thursday it had begun a study to evaluate the combination of antibiotic azithromycin and hydroxychloroquine as a potential treatment for COVID-19.
Hinterlasse eine Antwort
Sie müssen... (sein)angemeldet sein um einen Kommentar zu schreiben.